glp-1 and gip mechanism of action The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology The antiemetic actions of GIP

3.13 Farnesoid X receptor agonist A crucial regulator of metabolic pathways, including glucose homeostasis, inflammation, and fibrosis, is the farnesoid X receptor (FXR)

W., Mahmood, R., Russell, R

Many shakes contain almost as much sugar and carbohydrate as they do protein

10-12 A 2018 systematic review and meta-analysis found SIBO to exist in IBS 38% of the time, being more common in females, older people, and those with IBS-D

Explored for combined amylin + GLP-1 signaling Researchers study whether pairing an amylin analog with a GLP-1 agonist adds to appetite-pathway effects beyond either component alone

Lost productivity, inability to participate in recreational activities, and the frustration of multiple failed treatments contribute to decreased quality of life